Revolving from Hypertension to Cardiovascular Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2812
Special Issue Editor
Interests: hypertension; heart failure; neurohormonal systems; cardiovascular prevention
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hypertension is the most common modifiable risk factor for cardiovascular (CV) disease and death. Strategies for lowering blood pressure (BP) significantly reduce the development of organ damage and contribute to the prevention of major CV events.
Although a great deal of progress has been made in BP management, clinical decision-making, better adherence to guidelines and patient engagement, and adequate BP control is still insufficiently achieved in a proportion of subjects.
New drug classes such as vasopeptidases, aldosterone synthase, and soluble epoxide hydrolase inhibitors; agonists of natriuretic peptide A and vasoactive intestinal peptide receptor 2; novel mineralocorticoid receptor antagonist inhibitors of aminopeptidase A, dopamine β-hydroxylase, and intestinal Na+/H+ exchanger 3; agonists of components of the angiotensin-converting enzyme 2/angiotensin(1–7)/Mas receptor axis endothelin receptor; and antagonists and vaccines against angiotensin II and its type 1 receptor are being tested in preclinical studies and are in phase II and III trials.
The Special Issue, “Revolving From Hypertension to Cardiovascular Disease", aims to provide a research platform for a collection of the latest original and review articles that cover new insight into the biological mechanisms that are involved in the pathogenesis of hypertension, with the hopes of representing potential future therapeutic targets.
Prof. Dr. Massimo Volpe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hypertension
- blood pressure
- cardiovascular disease
- molecular mechanisms of hypertension
- antihypertensive drugs
- hypertension-mediated organ damage
